secwatch.observer — SEC 8-K summary
======================================

Issuer:     OPKO HEALTH, INC. (OPK)
CIK:        0000944809
Form:       8-K
Filed at:   2024-03-29T23:59:59+00:00
Accession:  0001437749-24-010069
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

OPKO Health stockholders approve share increase to 1.25B, elect all 11 directors
--------------------------------------------------------------------------------

- Authorized share increase from 1B to 1.25B approved with 492.4M for, 37.9M against.
- All 11 director nominees elected; votes ranged from 409.3M to 438.3M for each.
- Non-binding advisory vote on named executive officer compensation passed with 431.1M for.
- Ratification of Ernst & Young as independent auditor for FY2024 approved with 519.6M for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/944809/000143774924010069/0001437749-24-010069-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/944809/000143774924010069/opk20240220c_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-010069

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer